Probiotec Limited

Equities

PBP

AU000000PBP7

Pharmaceuticals

Market Closed - Australian S.E. 02:10:45 2024-04-26 am EDT 5-day change 1st Jan Change
2.83 AUD -0.35% Intraday chart for Probiotec Limited -0.35% -2.41%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Probiotec Limited Declares Interim Dividend, Payable on 15 March 2024 CI
Probiotec Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI
Probiotec Enters Scheme Implementation Bid With Indonesia-Listed Pyridam Farma MT
Probiotec Limited Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Probiotec Limited Declares Fully Franked Final Dividend for the Period of Six Months Ended June 30, 2023 , Payable on 8 September 2023 CI
Probiotec Limited Provides Sales Guidance for the Fiscal 2023 CI
Probiotec Limited Declares an Interim Dividend Payable on 17 March 2023 CI
Probiotec Limited Reports Earnings Results for the Half Year Ended December 31, 2022 CI
Probiotec to Consolidate NSW Operations with New Large-Scale Facility in Sydney MT
Probiotec Limited Enters Agrees Terms with Major Australian Developer for Circa 30,000 Sqm Facility in Kemps Creek, NSW CI
Probiotec Limited Announces Resignation of Paul Santoro as Non-Executive Director CI
Probiotec Limited(ASX:PBP) dropped from S&P/ASX Emerging Companies Index CI
Probiotec Limited Reports Earnings Results for the Full Year Ended June 30, 2022 CI
Probiotec Limited Announces Ordinary Fully Paid Dividend for the Twelve Months Ended June 30, 2022, Payable on September 15, 2022 CI
Probiotec Limited Provides Earnings Guidance for the Full Year 2022 CI
Probiotec Limited Reports Earnings Results for the Half Year Ended December 31, 2021 CI
Probiotec Limited Announces Distribution for the Six Months Ended December 31, 2021, Payable on March 18, 2022 CI
Probiotec Limited Appoints Paul Santoro as Non-Executive Director CI
Probiotec Limited Reports Earnings Results for the Full Year Ended June 30, 2021 CI
Probiotec Limited Declares Final Dividend for the Financial Year Ended 30 June 2021, Payable on 8 October 2021 CI
Probiotec : Acquires H&H Packaging for Up to $2.9 Million MT
Probiotec Limited (ASX: PBP) completed the acquisition of assets and business of H&H Packaging. CI
Probiotec : To Acquire H&H Packaging for up to $3 Million; Shares Up 5% MT
Probiotec Limited Appoints Simon Gray as an Independent Non-Executive Director, Effective 1 July 2021 CI
Probiotec Limited entered in an agreement to acquire assets and business of H&H Packaging Pty Ltd for AUD 4 million. CI
Chart Probiotec Limited
More charts
Probiotec Limited is an Australia-based manufacturer, packer and distributor of a range of prescription and over the counter (OTC) pharmaceuticals, complementary medicines, consumer health products, and fast-moving consumer goods (FMCG). The Company owns approximately six manufacturing facilities in Australia and distributes its products both domestically and internationally. It offers full-service contract manufacturing and packing. The Company manufactures products on behalf of a range of clients, including international pharmaceutical companies. The Company services blue-chip manufacturers, multinational FMCG companies, local manufacturers and brand custodians. All types of FMCG products are packed or handled, such as canned food, alcohol, tea and coffee, dairy and frozen foods, sauces and condiments, and bottled water. Its subsidiaries include Probiotec Pharmaceuticals Pty Ltd, Probiotec Pharma Pty Ltd, Multipack-LJM Pty Ltd, LJM (NSW) Pty Ltd and HH Packaging Pty Ltd.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
2.83 AUD
Average target price
3 AUD
Spread / Average Target
+6.01%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. PBP Stock
  4. News Probiotec Limited
  5. Probiotec to Consolidate NSW Operations with New Large-Scale Facility in Sydney